Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 1, 1986
[A randomized control study of the antiemetic efficacy of betamethasone versus methylprednisolone]
K Matsui, M Fukuoka, Y Kusunoki, et al.
The Journal of Clinical Investigation
|
March 1, 1995
Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy
N Negoro, Y Kanayama, M Haraguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
May 1, 1985
[A case of congenital stomatocytosis with decreased red cell sodium content, increased red cell sodium efflux and pulmonary embolism]
K Murai, K Yasunari, M Yasuda, et al.
Atherosclerosis
|
July 11, 1997
Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (Cip1)
R Fukui, N Shibata, E Kohbayashi, et al.
Scandinavian Journal of Rheumatology
|
June 6, 2022
Retroperitoneal fibrosis requiring prompt nephrostomy in a case with immunoglobulin A vasculitis
Y Ishihama, K Fukumoto, R Watanabe, et al.
Journal of Cardiology
|
March 14, 2000
Angiographically demonstrated coronary collaterals predict residual viable myocardium in patients with chronic myocardial infarction: a regional metabolic study
M Fukai, M Ii, T Nakakoji, et al.
Biochemical and Biophysical Research Communications
|
August 17, 1999
The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells
N Negoro, M Hoshiga, M Seto, et al.
American Journal of Physiology. Cell Physiology
|
September 26, 2000
Increased migration in late G(1) phase in cultured smooth muscle cells
R Fukui, M Amakawa, M Hoshiga, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 1, 1986
[A randomized control study of the antiemetic efficacy of betamethasone versus methylprednisolone]
K Matsui, M Fukuoka, Y Kusunoki, et al.
The Journal of Clinical Investigation
|
March 1, 1995
Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy
N Negoro, Y Kanayama, M Haraguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
May 1, 1985
[A case of congenital stomatocytosis with decreased red cell sodium content, increased red cell sodium efflux and pulmonary embolism]
K Murai, K Yasunari, M Yasuda, et al.
Atherosclerosis
|
July 11, 1997
Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (Cip1)
R Fukui, N Shibata, E Kohbayashi, et al.
Scandinavian Journal of Rheumatology
|
June 6, 2022
Retroperitoneal fibrosis requiring prompt nephrostomy in a case with immunoglobulin A vasculitis
Y Ishihama, K Fukumoto, R Watanabe, et al.
Journal of Cardiology
|
March 14, 2000
Angiographically demonstrated coronary collaterals predict residual viable myocardium in patients with chronic myocardial infarction: a regional metabolic study
M Fukai, M Ii, T Nakakoji, et al.
Biochemical and Biophysical Research Communications
|
August 17, 1999
The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells
N Negoro, M Hoshiga, M Seto, et al.
American Journal of Physiology. Cell Physiology
|
September 26, 2000
Increased migration in late G(1) phase in cultured smooth muscle cells
R Fukui, M Amakawa, M Hoshiga, et al.
Page
of 5